$PRPH
ProPhase Labs, Inc.

2023 Q3 Form 10-Q Financial Statement

#000086827823000014 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $8.365M $13.22M $29.10M
YoY Change -65.43% -54.58% 219.78%
Cost Of Revenue $6.038M $6.769M $10.37M
YoY Change -50.62% -34.74% 121.81%
Gross Profit $2.327M $6.448M $18.72M
YoY Change -80.56% -65.56% 319.17%
Gross Profit Margin 27.82% 48.79% 64.33%
Selling, General & Admin $8.250M $9.937M $6.306M
YoY Change 9.82% 57.58% 26.3%
% of Gross Profit 354.53% 154.11% 33.69%
Research & Development $428.0K $572.0K $28.00K
YoY Change 289.09% 1942.86% -69.89%
% of Gross Profit 18.39% 8.87% 0.15%
Depreciation & Amortization $1.800M $1.347M $607.0K
YoY Change 233.33% 121.91% 28.06%
% of Gross Profit 77.35% 20.89% 3.24%
Operating Expenses $8.805M $11.11M $8.133M
YoY Change -12.13% 36.55% 37.47%
Operating Profit -$6.478M -$4.658M $10.59M
YoY Change -431.69% -144.0% -830.14%
Interest Expense $275.0K $291.0K $201.0K
YoY Change 36.82% 44.78% -37.77%
% of Operating Profit 1.9%
Other Income/Expense, Net -$33.00K $8.000K $0.00
YoY Change
Pretax Income -$6.785M -$4.914M $10.41M
YoY Change -481.82% -147.2% -846.31%
Income Tax -$1.644M -$1.474M $2.965M
% Of Pretax Income 28.48%
Net Earnings -$5.141M -$3.440M $7.446M
YoY Change -631.1% -146.2% -633.76%
Net Earnings / Revenue -61.46% -26.03% 25.59%
Basic Earnings Per Share -$0.30 -$0.20 $0.48
Diluted Earnings Per Share -$0.30 -$0.20 $0.40
COMMON SHARES
Basic Shares Outstanding 16.85M shares 17.18M shares 15.58K shares
Diluted Shares Outstanding 17.18M shares 16.85K shares 19.27K shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.267M $9.104M $27.50M
YoY Change -87.66% -66.89% -24.15%
Cash & Equivalents $702.0K $3.824M $23.96M
Short-Term Investments $2.565M $5.280M $3.539M
Other Short-Term Assets $2.830M $3.667M $1.598M
YoY Change 156.11% 129.47% 273.36%
Inventory $5.054M $3.623M $4.509M
Prepaid Expenses
Receivables $38.64M $38.57M $36.67M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $49.79M $54.97M $70.28M
YoY Change -29.2% -21.78% 20.14%
LONG-TERM ASSETS
Property, Plant & Equipment $13.16M $8.831M $6.252M
YoY Change 117.1% 41.25% -45.53%
Goodwill $5.231M $5.231M $5.709M
YoY Change -8.37% -8.37%
Intangibles $13.02M $13.77M $9.434M
YoY Change 46.42% 45.95%
Long-Term Investments
YoY Change
Other Assets $1.163M $1.163M $1.282M
YoY Change -9.28% -9.28% -71.09%
Total Long-Term Assets $41.92M $36.09M $27.67M
YoY Change 52.14% 30.43% 55.19%
TOTAL ASSETS
Total Short-Term Assets $49.79M $54.97M $70.28M
Total Long-Term Assets $41.92M $36.09M $27.67M
Total Assets $91.71M $91.06M $97.95M
YoY Change -6.3% -7.03% 28.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.467M $4.786M $4.445M
YoY Change 253.85% 7.67% -37.52%
Accrued Expenses $1.300M $1.527M $226.0K
YoY Change 296.34% 575.66% -90.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.840M $364.0K
YoY Change
Total Short-Term Liabilities $16.41M $13.68M $16.72M
YoY Change -1.72% -18.22% 17.98%
LONG-TERM LIABILITIES
Long-Term Debt $4.440M $3.490M $7.998M
YoY Change -44.49% -56.36% -19.97%
Other Long-Term Liabilities $14.44M $14.64M $5.069M
YoY Change 174.32% 188.74% 14.63%
Total Long-Term Liabilities $18.88M $18.13M $13.07M
YoY Change 42.32% 38.72% -9.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.41M $13.68M $16.72M
Total Long-Term Liabilities $18.88M $18.13M $13.07M
Total Liabilities $35.28M $31.80M $29.79M
YoY Change 17.78% 6.75% 4.19%
SHAREHOLDERS EQUITY
Retained Earnings $3.722M $8.863M $13.23M
YoY Change -73.79% -33.01%
Common Stock $18.00K $17.00K $16.00K
YoY Change 5.88% 6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.02M
YoY Change
Treasury Stock Shares 17.35M shares
Shareholders Equity $56.43M $59.26M $68.16M
YoY Change
Total Liabilities & Shareholders Equity $91.71M $91.06M $97.95M
YoY Change -6.3% -7.03% 28.33%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$5.141M -$3.440M $7.446M
YoY Change -631.1% -146.2% -633.76%
Depreciation, Depletion And Amortization $1.800M $1.347M $607.0K
YoY Change 233.33% 121.91% 28.06%
Cash From Operating Activities -$4.660M -$6.957M $4.821M
YoY Change -277.05% -244.31% 8.58%
INVESTING ACTIVITIES
Capital Expenditures $670.0K -$2.244M -$674.0K
YoY Change -220.94% 232.94% 119.54%
Acquisitions
YoY Change
Other Investing Activities $1.000M -$1.029M $186.0K
YoY Change -962.07% -653.23% -101.27%
Cash From Investing Activities $330.0K $1.215M -$488.0K
YoY Change -149.25% -348.98% -96.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.200M -47.00K -6.181M
YoY Change -138.44% -99.24% 35.82%
NET CHANGE
Cash From Operating Activities -4.660M -6.957M 4.821M
Cash From Investing Activities 330.0K 1.215M -488.0K
Cash From Financing Activities 1.200M -47.00K -6.181M
Net Change In Cash -3.130M -5.789M -1.848M
YoY Change 169.83% 213.26% -87.73%
FREE CASH FLOW
Cash From Operating Activities -$4.660M -$6.957M $4.821M
Capital Expenditures $670.0K -$2.244M -$674.0K
Free Cash Flow -$5.330M -$4.713M $5.495M
YoY Change -267.29% -185.77% 15.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
prph Change In Fair Value Of Investment Securities
ChangeInFairValueOfInvestmentSecurities
-76000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
47000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
496000 usd
CY2023Q2 prph Prepaid Share Based Compensation Expense
PrepaidShareBasedCompensationExpense
1251000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2307000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3440000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
59257000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
66445000 usd
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1458000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4705000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-98000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
528000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
7446000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
68158000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
63631000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
588000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
398000 usd
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-5379000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-169000 usd
prph Prepaid Share Based Compensation Expense
PrepaidShareBasedCompensationExpense
1251000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3254000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2890000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
59257000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
58628000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
600000 usd
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1458000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1150000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9351000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-61000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1010000 usd
us-gaap Net Income Loss
NetIncomeLoss
19940000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
68158000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2890000 usd
us-gaap Net Income Loss
NetIncomeLoss
19940000 usd
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-108000 usd
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-186000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2639000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2516000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
44000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
217000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
168000 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-74000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2003000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1010000 usd
prph Change In Fair Value Of Investment Securities
ChangeInFairValueOfInvestmentSecurities
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
718000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1988000 usd
prph Inventory Valuation Reserve
InventoryValuationReserve
0 usd
prph Inventory Valuation Reserve
InventoryValuationReserve
25000 usd
prph Noncash Interest Income On Secured Promissory Note Receivable
NoncashInterestIncomeOnSecuredPromissoryNoteReceivable
194000 usd
prph Noncash Interest Income On Secured Promissory Note Receivable
NoncashInterestIncomeOnSecuredPromissoryNoteReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2042000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
941000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-353000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-66000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1661000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-104000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1790000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
594000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
674000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1119000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2583000 usd
prph Increase Decrease In Accrued Diagnostic Services
IncreaseDecreaseInAccruedDiagnosticServices
-667000 usd
prph Increase Decrease In Accrued Diagnostic Services
IncreaseDecreaseInAccruedDiagnosticServices
-1130000 usd
prph Increase Decrease In Accrued Advertising And Other Allowances
IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances
-28000 usd
prph Increase Decrease In Accrued Advertising And Other Allowances
IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances
51000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-198000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
474000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-307000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-154000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-147000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1798000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5475000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
285000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-978000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6481000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25108000 usd
us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
478000 usd
us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2904000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3819000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
607000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4168000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
5600000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2817000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
372000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1177000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1769000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-437000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3596000 usd
prph Proceeds From Issuance Of Common Stock And Warrants From Private Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromPrivateOffering
7600000 usd
prph Proceeds From Issuance Of Common Stock And Warrants From Private Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromPrivateOffering
0 usd
prph Repurchase Of Common Stock For Payment Of Statutory Taxes Due On Cashless Exercise Of Stock Option
RepurchaseOfCommonStockForPaymentOfStatutoryTaxesDueOnCashlessExerciseOfStockOption
5379000 usd
prph Repurchase Of Common Stock For Payment Of Statutory Taxes Due On Cashless Exercise Of Stock Option
RepurchaseOfCommonStockForPaymentOfStatutoryTaxesDueOnCashlessExerciseOfStockOption
1458000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
588000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1150000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1444000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
9351000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1633000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13403000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5285000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15301000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9109000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8658000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3824000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23959000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-3000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1500000 usd
us-gaap Interest Paid Net
InterestPaidNet
690000 usd
us-gaap Interest Paid Net
InterestPaidNet
441000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1251000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
prph Issuance Of Common Shares For Debt Conversion
IssuanceOfCommonSharesForDebtConversion
0 usd
prph Issuance Of Common Shares For Debt Conversion
IssuanceOfCommonSharesForDebtConversion
600000 usd
prph Unrealized Loss Investments In Marketable Debt Securities
UnrealizedLossInvestmentsInMarketableDebtSecurities
258000 usd
prph Unrealized Loss Investments In Marketable Debt Securities
UnrealizedLossInvestmentsInMarketableDebtSecurities
-61000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1495000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
prph Warrants Issued
WarrantsIssued
398000 usd
prph Warrants Issued
WarrantsIssued
0 usd
us-gaap Stock Issued1
StockIssued1
1000000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q3 prph Number Of Inhibitors
NumberOfInhibitors
2 inhibitor
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements and the accompanying notes thereto, in conformity with GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration of diagnostic test reimbursement rates, the provision for uncollectible receivables and billing errors, allowances, slow moving and/or dated inventory and associated provisions, the potential impairment of long-lived assets, stock based compensation valuations, income tax asset valuations and assumptions related to accrued advertising.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the condensed consolidated financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.</span></div>
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
5280000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
8328000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2583000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2583000 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
500000 usd
CY2022Q4 prph Asset Acquisition Consideration Transferred Liability Payoff
AssetAcquisitionConsiderationTransferredLiabilityPayoff
1600000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2022Q4 prph Asset Acquisition Shares Issued And Issuable Value Per Share
AssetAcquisitionSharesIssuedAndIssuableValuePerShare
10.00
CY2022Q4 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
4600000 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
500000 usd
CY2022Q4 prph Asset Acquisition Consideration Transferred Promissory Note Payoff
AssetAcquisitionConsiderationTransferredPromissoryNotePayoff
400000 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
2000000 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
2000000 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
2000000 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
2000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P7Y
CY2022Q4 prph Asset Acquisition Transaction Costs
AssetAcquisitionTransactionCosts
200000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19101000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12297000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5332000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3822000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13769000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8475000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1436000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2251000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1731000 usd
CY2023Q2 prph Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
3185000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13769000 usd
CY2022Q1 us-gaap Cash
Cash
1441000 usd
CY2022Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1400000 usd
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
41000 usd
CY2022Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
5.75
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1150000 usd
CY2022Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
2591000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0005
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4600000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4700000 usd
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
6000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P6M
CY2021Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
6000000 usd
CY2021Q3 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
120000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1125000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
4100000 usd
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
7.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
744369 shares
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5400000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
603881 shares
CY2023Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
10.00
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
300000 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y
CY2023Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
prph Share Based Payment Arrangement Expense Remaining
ShareBasedPaymentArrangementExpenseRemaining
7800000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M18D
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3496
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0290
CY2021Q2 prph Manufacturing Agreement Renewal Options
ManufacturingAgreementRenewalOptions
4 periods
CY2021Q2 prph Manufacturing Agreement Renewal Period
ManufacturingAgreementRenewalPeriod
P1Y
CY2021Q2 prph Agreement Term
AgreementTerm
P90D
CY2022Q3 prph License Agreement Term
LicenseAgreementTerm
P10D
CY2023Q1 prph Number Of Sites
NumberOfSites
12 site
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
5400000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4600000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4800000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4100000 usd
CY2023Q2 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P5Y
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1500000 usd
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
50000 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
20000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
298000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
204000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
502000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
408000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
298000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
204000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
502000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
408000 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
20000 usd
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
20000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
50000 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
50000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
CY2023Q2 prph Finance Lease Cost
FinanceLeaseCost
70000 usd
CY2022Q2 prph Finance Lease Cost
FinanceLeaseCost
0 usd
prph Finance Lease Cost
FinanceLeaseCost
70000 usd
prph Finance Lease Cost
FinanceLeaseCost
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
397000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
387000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.08
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1445000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
50000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
465000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
181000 usd
CY2023Q2 prph Lease Liability To Be Paid Remainder Of Fiscal Year
LeaseLiabilityToBePaidRemainderOfFiscalYear
646000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
953000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
364000 usd
CY2023Q2 prph Lease Liability To Be Paid Year One
LeaseLiabilityToBePaidYearOne
1317000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
978000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
364000 usd
CY2023Q2 prph Lease Liability To Be Paid Year Two
LeaseLiabilityToBePaidYearTwo
1342000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
942000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
364000 usd
CY2023Q2 prph Lease Liability To Be Paid Year Three
LeaseLiabilityToBePaidYearThree
1306000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
956000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
364000 usd
CY2023Q2 prph Lease Liability To Be Paid Year Four
LeaseLiabilityToBePaidYearFour
1320000 usd
CY2023Q2 prph Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3650000 usd
CY2023Q2 prph Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
121000 usd
CY2023Q2 prph Lease Liability Payments Due After Year Four
LeaseLiabilityPaymentsDueAfterYearFour
3771000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7944000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1758000 usd
CY2023Q2 prph Lease Liability To Be Paid
LeaseLiabilityToBePaid
9702000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2551000 usd
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
304000 usd
CY2023Q2 prph Lease Liability Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
2855000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
5393000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
1454000 usd
CY2023Q2 prph Lease Liability
LeaseLiability
6847000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13217000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29092000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32520000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76623000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6769000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10372000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15552000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29226000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
517000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1195000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1754000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2371000 usd
CY2023Q2 prph Operating And Other Expenses
OperatingAndOtherExpenses
10845000 usd
CY2022Q2 prph Operating And Other Expenses
OperatingAndOtherExpenses
7114000 usd
prph Operating And Other Expenses
OperatingAndOtherExpenses
19564000 usd
prph Operating And Other Expenses
OperatingAndOtherExpenses
18705000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4914000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10411000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4350000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26321000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1474000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2965000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1460000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6381000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3440000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7446000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2890000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
19940000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3440000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
7446000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2890000 usd
us-gaap Net Income Loss
NetIncomeLoss
19940000 usd
CY2023Q2 us-gaap Assets
Assets
91058000 usd
CY2022Q4 us-gaap Assets
Assets
87648000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3440000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7446000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2890000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19940000 usd
CY2023Q2 prph Interest On Unsecured Convertible Promissory Note
InterestOnUnsecuredConvertiblePromissoryNote
0 usd
CY2022Q2 prph Interest On Unsecured Convertible Promissory Note
InterestOnUnsecuredConvertiblePromissoryNote
200000 usd
prph Interest On Unsecured Convertible Promissory Note
InterestOnUnsecuredConvertiblePromissoryNote
0 usd
prph Interest On Unsecured Convertible Promissory Note
InterestOnUnsecuredConvertiblePromissoryNote
432000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3440000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7646000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2890000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
20372000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16845 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15576 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16797 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15531 shares
CY2023Q2 prph Incremental Common Shares Attributable To Call Options
IncrementalCommonSharesAttributableToCallOptions
0 shares
CY2022Q2 prph Incremental Common Shares Attributable To Call Options
IncrementalCommonSharesAttributableToCallOptions
2635 shares
prph Incremental Common Shares Attributable To Call Options
IncrementalCommonSharesAttributableToCallOptions
0 shares
prph Incremental Common Shares Attributable To Call Options
IncrementalCommonSharesAttributableToCallOptions
2389 shares
CY2023Q2 prph Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
0 shares
CY2022Q2 prph Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
261 shares
prph Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
0 shares
prph Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
244 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
800 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
800 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16845 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19272 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16797 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18964 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4922000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
730000 shares

Files In Submission

Name View Source Status
0000868278-23-000014-index-headers.html Edgar Link pending
0000868278-23-000014-index.html Edgar Link pending
0000868278-23-000014.txt Edgar Link pending
0000868278-23-000014-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
prph-20230630.htm Edgar Link pending
prph-20230630.xsd Edgar Link pending
prph-20230630xexx3111.htm Edgar Link pending
prph-20230630xexx3121.htm Edgar Link pending
prph-20230630xexx3211.htm Edgar Link pending
prph-20230630xexx3221.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
prph-20230630_cal.xml Edgar Link unprocessable
prph-20230630_def.xml Edgar Link unprocessable
prph-20230630_lab.xml Edgar Link unprocessable
prph-20230630_pre.xml Edgar Link unprocessable
prph-20230630_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending